Linda Coleman joined Yale University in 2016, and is the Director of the Human Research Protection Program.  In this capacity, Ms. Coleman is responsible for the oversight and administration of Yale’s comprehensive Human Research Protection Program and oversees the Institutional Review Board (19 panels) and several non-IRB committees such as the Radiation Drug Research Committee, Radiation Drug Investigation Committee, Institutional Conflict of Interest Committee (in collaboration with the Conflict of Interest office), and Embryonic Stem Cell Research Oversight Committee. She also serves on several Yale committees and working groups including the Investigator Conflict of Interest Committee, Institutional Biological Committee/Human Gene Transfer Subcommittee, Clinical and Translational Research Oversight Committee, Data Safety Monitoring Committee, Cancer Center Clinical Trials Advisory Committee, Data Privacy Advisory Council, and the Yale University/Yale New Haven Health System Health Data Governance Council.  Before her tenure at Yale, Ms. Coleman held various positions at Quorum Review (now Advarra), an independent IRB and consulting organization serving institutional, independent, and international research sites. She served as Vice President of Legal & Regulatory Affairs in 2016, Director of Regulatory Affairs & General Counsel from 2011 to 2016, and Director of Regulatory Affairs from 2007 to 2011. Earlier in her career, Ms. Coleman worked as an Associate Attorney at Bennett, Bigelow & Leedom, specializing in general health law matters, Medicare and Medicaid reimbursement, litigation, behavioral health, and employment law.